Neoadjuvant Immune Checkpoint Inhibitor Reduced Recurrence in Operable NSCLC Patients with Pathological Complete Response: a Retrospective Analysis
BMC CANCER（2024）
Key words
NSCLC,Immune checkpoint inhibitor,Pathological complete response,Neoadjuvant therapy,Recurrence
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined